機器人放射線治療市場－全球產業規模、佔有率、趨勢、機會及預測（按產品、技術、應用、最終用戶、地區和競爭格局分類，2021-2031年）

全球機器人放射治療市場預計將從 2025 年的 20.4 億美元成長到 2031 年的 38.2 億美元，複合年成長率為 11.02%。

該領域利用採用機器人自動化技術的醫療系統，能夠精準地輸送放射線束，並即時追蹤受影響區域的移動。推動該市場成長要素是全球癌症負擔日益加重，以及對能夠最大限度減少對周圍器官毒性的非侵入性治療的需求不斷成長。此外，人口老化也促使人們尋求治療方法。美國癌症協會在2024年預測，到2050年，全球每年新增癌症病例將達3,500萬例，凸顯了大幅擴充放射治療能力的必要性。

市場推廣的一大障礙是購買和安裝設備所需的高額資本投入。這些成本往往超出發展中地區醫療機構的預算，導致採購僅限於都市區。這一經濟障礙顯著限制了市場滲透率，並加劇了經濟狀況各異的地區在獲得先進癌症治療方面的不平等。

市場促進因素

即時影像處理和運動控制技術的進步是全球機器人放射治療市場的關鍵驅動力，徹底改變了治療的精確度和安全性。現代機器人系統整合了人工智慧演算法和連續影像引導功能，能夠動態調整放射劑量，確保將高劑量輻射精準輸送到靶區，同時最大限度地減少對正常組織的影響。這種能力正在推動大量的投資。例如，醫療器材網路（Medical Device Network）在2024年11月報道稱，Zap Surgical Systems已成功資金籌措7,800萬美元，用於加速其保險箱的放射線手術平台的全球擴張。此外，Accuray Incorporated在2024年8月宣布，其2024會計年度的總訂單金額達到3.421億美元，證實了市場對高精度機器人系統的強勁臨床需求。

第二個關鍵促進因素是醫療基礎設施的擴張和政府投資的增加，這提高了新興市場和成熟市場獲得資本密集機器人解決方案的途徑。各國政府日益重視腫瘤科的現代化改造，以縮短病患等待時間並提高存活率。例如，根據英國國家衛生執行局2024年10月發布的消息，英國政府宣布投資7,000萬英鎊，以最新技術升級老舊的放射治療設備，以縮短等待時間。此類公共部門的努力對於克服經濟障礙、使世界各地更多醫療機構能夠提供先進的癌症治療至關重要。

市場挑戰

實施和安裝機器人放射治療系統所需的大量資本投入，對全球市場擴張構成了重大障礙。這些先進系統價格昂貴，往往超出醫療機構的預算，尤其是在開發中國家和農村地區。因此，採購通常僅限於資源充足的大規模大都會圈，導致廣大地區無法獲得精準癌症治療。這種經濟壁壘直接阻礙了市場滲透，妨礙了推動銷售成長和規模經濟所需的廣泛應用。

成本限制的影響顯而易見，全球設備分佈極度不均，限制了潛在市場規模。核能（IAEA）2024年報告稱，低收入國家平均每1,560萬人僅擁有一台放射治療設備，而高所得國家平均每13萬人約有一台。這種巨大的設備差距凸顯了高昂的資本投入如何有效地將很大一部分潛在全球基本客群拒之門外，阻礙了新興市場機器人放射治療市場的整體成長。

市場趨勢

向低分割和立體定位治療通訊協定的轉變正在從根本上重塑市場格局，它將治療壓縮到更少次數、更高劑量的療程中，即所謂的「立體定位體部放射治療（SBRT）」。這種轉變在保持治療效果的同時，最大限度地提高了設備吞吐量和患者便利性，從而在現有設施無需立即擴充硬體的情況下，顯著提升了治療能力。近期的數據也反映了這種轉變的規模：根據 Medscape Medical News 2024 年 12 月對超過一百萬份患者記錄的分析，64% 的浸潤性乳癌患者接受了低分割放射治療，這有力地支持了向這些加速治療標準的明確轉變。

同時，磁振造影引導機器人加速器的廣泛應用正在革新軟組織標靶治療，它能夠在放射治療過程中提供腫瘤的高解析度視覺化影像。與傳統的X光引導不同，這些混合系統使臨床醫生能夠即時觀察解剖結構的變化，從而實現更嚴格的安全邊界，保護重要結構並最大限度地減少副作用。 Elekta公司在2025年5月舉行的歐洲放射腫瘤學會（ESTRO）年會上發表的ERECT試驗結果證實了該技術的良好毒性特徵。研究發現，接受Unity MR-Linac治療的男性患者6個月內勃起功能障礙發生率僅6%，而接受傳統放射治療的患者比例為21%。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球機器人放射線治療市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品分類（放射治療系統、軟體、3D相機（表面導引）、其他）
  • 依技術分類（直線加速器、傳統直線加速器、MRI直線加速器、立體定位放射治療系統、電腦刀、伽瑪刀、粒子治療、質子治療、重離子治療）
  • 依應用領域（前列腺癌、乳癌、肺癌、頭頸癌、結腸癌、其他癌症）
  • 依最終使用者（醫院、獨立放射治療中心）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美機器人放射線治療市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲機器人放射線治療市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區機器人放射線治療市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲機器人放射線治療市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美機器人放射線治療市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球機器人放射線治療市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Accuray
• Varian
• Elekta
• ViewRay
• IBA
• Hitachi
• Mevion Medical Systems
• RaySearch Laboratories
• Siemens Healthineers
• Alphatec

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Robotic Radiotherapy Market is projected to expand from USD 2.04 Billion in 2025 to USD 3.82 Billion by 2031, registering a CAGR of 11.02%. This sector involves medical systems that use robotic automation to deliver focused radiation beams with high precision and real-time motion tracking. The market is primarily driven by the rising global burden of cancer and a growing preference for noninvasive procedures that minimize toxicity to surrounding organs. Furthermore, the aging population is fueling demand for treatments that provide greater patient comfort and shorter durations. In '2024', the 'American Cancer Society' estimated that annual global cancer diagnoses will reach 35 million by 2050, highlighting the need for substantial radiotherapy capacity expansion.

A significant barrier to widespread market adoption is the high capital expenditure required for equipment acquisition and installation. These costs often exceed the budgets of healthcare facilities in developing regions, restricting procurement to major metropolitan centers. This financial hurdle severely limits market penetration and worsens the inequality in access to advanced cancer care across different economic geographies.

Market Driver

Technological advancements in real-time imaging and motion management are a primary catalyst for the Global Robotic Radiotherapy Market, revolutionizing treatment precision and safety. Modern robotic systems integrate AI algorithms with continuous image guidance to dynamically adjust radiation delivery, ensuring high doses reach the target while sparing healthy tissue. This capability has spurred significant investment; for example, Medical Device Network reported in November 2024 that Zap Surgical Systems secured $78 million to accelerate the global distribution of its vault-free gyroscopic radiosurgery platform. Additionally, Accuray Incorporated reported gross orders of $342.1 million for fiscal year 2024 in August 2024, underscoring the strong clinical demand for high-precision robotic systems.

The second key driver is the expansion of healthcare infrastructure and government funding, which improves access to capital-intensive robotic solutions in both emerging and established markets. Governments are increasingly prioritizing the modernization of oncology departments to address patient backlogs and improve survival rates. For instance, according to National Health Executive in October 2024, the UK government announced a £70 million investment to replace outdated radiotherapy machines with modern technology to reduce waiting lists. Such public sector initiatives are vital for overcoming financial barriers and ensuring advanced cancer care is available across a broader range of global facilities.

Market Challenge

The substantial capital expenditure needed to acquire and install robotic radiotherapy systems creates a major obstacle to the broader expansion of the global market. These advanced systems carry high price tags that frequently exceed the financial resources of healthcare institutions, particularly in developing economies and rural areas. As a result, procurement is often limited to well-funded metropolitan centers, leaving large geographic regions with insufficient access to precision cancer treatments. This financial barrier directly hampers market penetration by preventing the widespread adoption necessary to drive volume growth and economies of scale.

The impact of this cost constraint is evident in the severe global disparity in equipment distribution, which limits the addressable market. In '2024', the 'International Atomic Energy Agency' reported that low-income countries possess only one radiotherapy machine for every 15.6 million people, compared to one machine for approximately 130,000 individuals in high-income nations. This significant equipment gap underscores how high capital requirements effectively exclude a large portion of the potential global customer base, stalling the overall growth trajectory of the robotic radiotherapy market in emerging sectors.

Market Trends

The shift toward hypofractionated and stereotactic treatment protocols is fundamentally restructuring the market by condensing therapy into fewer, higher-dose sessions known as stereotactic body radiation therapy (SBRT). This transition maximizes machine throughput and patient convenience while maintaining therapeutic efficacy, effectively increasing the capacity of existing centers without requiring immediate hardware expansion. The scale of this adoption is reflected in recent data; according to Medscape Medical News in December 2024, an analysis of over one million patient records showed that 64% of patients with invasive breast cancer received hypofractionated radiation, validating the decisive move toward these accelerated standards.

Simultaneously, the proliferation of MRI-guided robotic linear accelerators is revolutionizing soft-tissue targeting by enabling high-definition visualization of tumors during radiation delivery. Unlike standard X-ray guidance, these hybrid systems allow clinicians to observe anatomical changes in real-time and reduce safety margins, thereby sparing critical structures and minimizing side effects. The superior toxicity profile of this technology was confirmed when, according to Elekta in May 2025, results from the ERECT trial presented at the ESTRO annual congress showed that men treated with the Unity MR-Linac had a six-month erectile dysfunction rate of only 6%, compared to 21% for those undergoing conventional radiotherapy.

Key Market Players

• Accuray
• Varian
• Elekta
• ViewRay
• IBA
• Hitachi
• Mevion Medical Systems
• RaySearch Laboratories
• Siemens Healthineers
• Alphatec

Report Scope

In this report, the Global Robotic Radiotherapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Robotic Radiotherapy Market, By Product

• Radiotherapy Systems
• Software
• 3D Cameras (Surface Guided)
• Others

Robotic Radiotherapy Market, By Technology

• Linear Accelerators
• Conventional Linear Accelerators
• MRI - Linear Accelerators
• Stereotactic Radiation Therapy Systems
• Cyberknife
• Gamma Knife
• Particle Therapy
• Proton Beam Therapy
• Heavy Ion beam Therapy

Robotic Radiotherapy Market, By Application

• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Head & Neck Cancer
• Colorectal Cancer
• Other

Robotic Radiotherapy Market, By End User

• Hospitals
• Independent Radiotherapy Centers

Robotic Radiotherapy Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Robotic Radiotherapy Market.

Available Customizations:

Global Robotic Radiotherapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Robotic Radiotherapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Radiotherapy Systems, Software, 3D Cameras (Surface Guided), Others)
  • 5.2.2. By Technology (Linear Accelerators, Conventional Linear Accelerators, MRI - Linear Accelerators, Stereotactic Radiation Therapy Systems, Cyberknife, Gamma Knife, Particle Therapy, Proton Beam Therapy, Heavy Ion beam Therapy)
  • 5.2.3. By Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, Colorectal Cancer, Other)
  • 5.2.4. By End User (Hospitals, Independent Radiotherapy Centers)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Robotic Radiotherapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Robotic Radiotherapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Robotic Radiotherapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Robotic Radiotherapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Robotic Radiotherapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Robotic Radiotherapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Robotic Radiotherapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Robotic Radiotherapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Robotic Radiotherapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Robotic Radiotherapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Robotic Radiotherapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Robotic Radiotherapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Robotic Radiotherapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Robotic Radiotherapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Robotic Radiotherapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Robotic Radiotherapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Robotic Radiotherapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Robotic Radiotherapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Robotic Radiotherapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Robotic Radiotherapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Robotic Radiotherapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Robotic Radiotherapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Robotic Radiotherapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Robotic Radiotherapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Robotic Radiotherapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Accuray
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Varian
• 15.3. Elekta
• 15.4. ViewRay
• 15.5. IBA
• 15.6. Hitachi
• 15.7. Mevion Medical Systems
• 15.8. RaySearch Laboratories
• 15.9. Siemens Healthineers
• 15.10. Alphatec

16. Strategic Recommendations

17. About Us & Disclaimer